First-in-human Phase I Clinical Trial of a Combined Immune Modulatory approach using TetMYB Vaccine and anti-PD1 antibody in patients with Advanced Solid Cancer including Colorectal or Adenoid Cystic Carcinoma (MYPHISMO)

Project: Research

NMA HREC Reference Number: HREC/17/PMCC/173
Monash Health Ref: RES-17-0000-656X

Status	Finished
Effective start/end date	4/01/19 → 3/01/24

Project Details